![Josef Zelinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 145 582 $ al 31/05/2026
Josef Zelinger currently works at Propanc Biopharma, Inc., as Independent Non-Executive Director from 2020.
Mr. Zelinger received his undergraduate degree in 1973 from RMIT University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PROPANC BIOPHARMA INC 3,51 % | 16/03/2026 | 79.990 ( 3,51 % ) | 145 582 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Director/Miembro de la Junta | 23/12/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Propanc Biopharma, Inc.
 Propanc Biopharma, Inc. BiotechnologyHealth Technology Operates as a development stage healthcare company which develops new cancer treatments for patients | Health Technology |
RMIT University
 RMIT University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
